Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma SubcommitteeChang, J. Y., Zhang, X., Knopf, A., Li, H., Mori, S., Dong, L., Lu, H-M., Liu, W., Badiyan, S. N., Both, S., Meijers, A., Lin, L., Flampouri, S., Li, Z., Umegaki, K., Simone, C. B. & Zhu, X. R. 1-Sep-2017 In : INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 99, 1, p. 41-50 10 p.
Research output: Scientific - peer-review › Review article
Pencil-beam scanning (PBS) proton therapy (PT), particularly intensity modulated PT, represents the latest advanced PT technology for treating cancers, including thoracic malignancies. On the basis of virtual clinical studies, PBS-PT appears to have great potential in its ability to tightly tailor the dose to the target while sparing critical structures, thereby reducing treatment-related toxicities, particularly for tumors in areas with complicated anatomy. However, implementing PBS-PT for moving targets has several additional technical challenges compared with intensity modulated photon radiation therapy or passive scattering PT. Four-dimensional computed tomographye based motion management and robust optimization and evaluation are crucial for minimizing uncertainties associated with beam range and organ motion. Rigorous quality assurance is required to validate dose delivery both before and during the course of treatment. Active motion management (eg, breath hold), beam gating, rescanning, tracking, or adaptive planning may be needed for cases involving significant motion or changes in motion or anatomy over the course of treatment. (C) 2017 The Authors. Published by Elsevier Inc.
|Number of pages||10|
|Journal||INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS|
|State||Published - 1-Sep-2017|
- CELL LUNG-CANCER, POLYMER GEL DOSIMETER, MOTION MITIGATION, RESPIRATORY MOTION, PARTICLE THERAPY, ROBUST OPTIMIZATION, RADIATION-THERAPY, MOVING TARGETS, TUMOR MOTION, TREATMENT UNCERTAINTIES